Cipla Launches First Breathefree Lung Wellness Centre in New Delhi

Cipla has announced the launch of its first Breathefree Lung Wellness Centre in New Delhi, marking the debut of what the company describes as India’s first integrated lung diagnostics and wellness facility, as per news reports  

 The centre is positioned to transform respiratory care by offering world-class, standardised lung diagnostics at an affordable cost to both medical professionals and patients. 

India’s Growing Respiratory Disease Burden 

Respiratory disorders continue to rise across India, with millions remaining either undiagnosed or misdiagnosed due to a lack of access to advanced pulmonary function tests and specialised diagnostic infrastructure. Cipla’s new centre is designed to address these gaps by serving as a one-stop platform for comprehensive lung-health assessments.  

The facility integrates advanced diagnostic technologies, globally benchmarked protocols and a team of highly trained technical professionals who perform tests with precision, enabling early and accurate detection of respiratory conditions. 

Management Commentary and Strategic Vision 

As per news reports, Achin Gupta, global chief operating officer at Cipla, said the launch represents a major step in strengthening India’s respiratory-care ecosystem. “Cipla has long been a pioneer in respiratory care, and with the launch of the first Breathefree Lung Wellness Centre, we are addressing a critical gap in the diagnostic landscape.  

 By expanding our presence across the care continuum, we are aiming to transform lung health diagnostics in India by making high-quality, standardised lung diagnostics accessible to healthcare professionals and patients, ultimately improving respiratory health outcomes,” he said. 

 Read More: Best Pharma Stocks in November 2025 - Neuland Labs, Wockhardt & More – 5yr CAGR Basis! 

Cipla Share Price Performance  

As of November 28, 2025, Cipla share price is closed at ₹1,530 per share, reflecting a surge of 0.31% from the previous closing price.  

Conclusion 

The Breathefree Lung Wellness Centre reflects Cipla’s broader strategy of enhancing respiratory health through advanced diagnostics, early intervention and improved accessibility. With the first centre now operational in the national capital, the company is expected to expand this model to other regions as India’s need for robust lung-health infrastructure continues to grow. 

 Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.